Scribd Logo
Upload

Welcome to Scribd!

  • 10 views

    March 3, 2021: BioNTech's Covid-19 Vaccine Debarment Certification

    Uploaded by

    Brian O'Shea
    This certifies the company will not use in any capacity the services of any person debarred under Section 306 of the Federal Food Drug and Cosmetic Act in connection with an application for marketing of a new vaccine or other drug.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    March 3, 2021: BioNTech's Covid-19 Vaccine Debarment Certification

    Uploaded by

    Brian O'Shea
    10 views1 page
    This certifies the company will not use in any capacity the services of any person debarred under Section 306 of the Federal Food Drug and Cosmetic Act in connection with an application for marketing of a new vaccine or other drug.

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This certifies the company will not use in any capacity the services of any person debarred under Section 306 of the Federal Food Drug and Cosmetic Act in connection with an application for marketing of a new vaccine or other drug.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    10 views1 page

    March 3, 2021: BioNTech's Covid-19 Vaccine Debarment Certification

    Uploaded by

    Brian O'Shea
    This certifies the company will not use in any capacity the services of any person debarred under Section 306 of the Federal Food Drug and Cosmetic Act in connection with an application for marketing of a new vaccine or other drug.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pdf or txt
    of 1

    %17E

     'HEDUPHQW &HUWLILFDWLRQ

    %/$ 

    &29,' 9$&&,1(

    '(%$50(17 &(57,),&$7,21

    >)' & $FW  N  @

    %LR17HFK 0DQXIDFWXULQJ *PE+ KHUHE\ FHUWLILHV WKDW LW GLG QRW DQG ZLOO QRW XVH LQ DQ\ FDSDFLW\
    WKH VHUYLFHV RI DQ\ SHUVRQ GHEDUUHG XQGHU 6HFWLRQ  RI WKH )HGHUDO )RRG 'UXJ DQG &RVPHWLF
    $FW LQ FRQQHFWLRQ ZLWK WKLV DSSOLFDWLRQ

    Digitally signed by Ruben Rizzi


    Ruben Rizzi
    BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
    Date: 2021.03.30 08:33:08
    +02'00'
    BBBBBBBBBBBBBBBBB
    6LJQDWXUH RI $SSOLFDQW 'DWH
    5XEHQ 5L]]L
    %LR17HFK 0DQXIDFWXULQJ *PE+

    Digitally signed by Neda Aghajani Memar


    Neda Aghajani DN: cn=Neda Aghajani Memar, o, ou,
    email=neda.aghajanimemar@pfizer.com, c=US
    Reason: I attest to the accuracy and integrity of this
    Memar document
    BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
    Date: 2021.03.29 15:07:36 -04'00'
    BBBBBBBBBBBBBBBBBB
    29 March 2021
    6LJQDWXUH RI $XWKRUL]HG 86 $JHQW 'DWH
    1HGD $JKDMDQL 0HPDU
    3IL]HU ,QF

    &21),'(17,$/
    3DJH 
    FDA-CBER-2021-5683-0013767

    You might also like